首页> 外文期刊>Clinical journal of the American Society of Nephrology: CJASN >Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD
【24h】

Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD

机译:肾小管细胞损伤的尿标记和肾功能下降冲刺试验参与者的CKD

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background and objectiveseGFR and albuminuria primarily reflect glomerular function and injury, whereas tubule cell atrophy and interstitial fibrosis on kidney biopsy are important risk markers for CKD progression. Kidney tubule injury markers have primarily been studied in hospitalized AKI. Here, we examined the association between urinary kidney tubule injury markers at baseline with subsequent loss of kidney function in persons with nondiabetic CKD who participated in the Systolic Blood Pressure Intervention Trial (SPRINT).Design, setting, participants, & measurementsAmong 2428 SPRINT participants with CKD (eGFR<60 ml/min per 1.73 m(2)) at baseline, we measured urine markers of tubule injury (IL-18, kidney injury molecule-1 [KIM-1], neutrophil gelatinase-associated lipocalin [NGAL]), inflammation (monocyte chemoattractant protein-1 [MCP-1]), and repair (human cartilage glycoprotein-40 [YKL-40]). Cox proportional hazards models evaluated associations of these markers with the kidney composite outcome of 50% eGFR decline or ESKD requiring dialysis or kidney transplantation, and linear mixed models evaluated annualized change in eGFR.ResultsMean participant age was 73?9 (SD) years, 60% were men, 66% were white, and mean baseline eGFR was 46?11 ml/min per 1.73 m(2). There were 87 kidney composite outcome events during a median follow-up of 3.8 years. Relative to the respective lowest quartiles, the highest quartiles of urinary KIM-1 (hazard ratio, 2.84; 95% confidence interval [95% CI], 1.31 to 6.17), MCP-1 (hazard ratio, 2.43; 95% CI, 1.13 to 5.23), and YKL-40 (hazard ratio, 1.95; 95% CI, 1.08 to 3.51) were associated with higher risk of the kidney composite outcome in fully adjusted models including baseline eGFR and urine albumin. In linear analysis, urinary IL-18 was the only marker associated with eGFR decline (?0.91 ml/min per 1.73 m(2) per year for highest versus lowest quartile; 95% CI, ?1.44 to ?0.38), a finding that was stronger in the standard arm of SPRINT.ConclusionsUrine markers of tubule cell injury provide information about risk of subsequent loss of kidney function, beyond the eGFR and urine albumin.
机译:背景和特视野和白蛋白尿素主要反映肾小球功能和损伤,而小管细胞萎缩和肾脏活检的间质纤维化是CKD进展的重要风险标志。肾小管损伤标志物主要在住院的AKI中进行了研究。在这里,我们研究了基线尿肾小管损伤标志物之间的关联,随后与参加收缩压干预试验(Sprint)的非糖果CKD的人的肾功能丧失.Design,Setting,参与者和测量amplint 2428 Sprint参与者CKD(EGFR <60mL / min / 0.73 m(2))在基线下,我们测量小管损伤的尿标记物(IL-18,肾损伤分子-1 [Kim-1],中性粒细胞明胶酶相关脂素[ngal]) ,炎症(单核细胞化学蛋白-1 [MCP-1])和修复(人软骨糖蛋白-40 [YKL-40])。 Cox比例危害模型评估这些标志物与需要透析或肾移植的50%EGFR下降或ESKD的肾复合结果评估这些标志物的关联,并且线性混合模型评估了EGFR.Resultsme​​an参与者年龄的年化变化为73?9(SD)年份,60 %是男性,66%是白色,平均基线EGFR为每1.73米(2)时为46×11ml / min。中位随访3.8岁,有87个肾脏复合结果活动。相对于各自的最低四分位数,尿基-1的最高四分位数(危险比,2.84; 95%置信区间[95%CI],1.31至6.17),MCP-1(危险比,2.43; 95%CI,1.13对于5.23)和YKL-40(危险比,1.95; 95%CI,1.08至3.51)与全调节模型的肾复合结果的风险较高有关,包括基线EGFR和尿白蛋白。在线性分析中,尿IL-18是唯一与EGFR下降相关的标记(每年0.91ml / min,最高与最低四分位数; 95%CI,?1.44至0.38),一个发现在Sprint的标准臂中更强烈。小管细胞损伤的链序标记物提供有关后续肾功能损失的风险的信息,超出EGFR和尿液白蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号